Quality of life beyond measure: Advanced cancer patients, wellbeing and medicinal cannabis
Abstract Experiences of advanced cancer are assembled and (re)positioned with reference to illness, symptoms and maintaining ‘wellbeing’. Medical cannabis is…
Rebecca E. Olson
‘What price do you put on your health?’: Medical cannabis, financial toxicity and patient perspectives on medication access in advanced cancer
Abstract Introduction: Following 2016 legislation permitting limited access to cannabis for research and medicinal purposes, the number of randomized clinical…
Using a qualitative sub-study to inform the design and delivery of randomised controlled trials on medicinal cannabis for symptom relief in patients with advanced cancer
Abstract Background: Recruitment for randomised controlled trials in palliative care can be challenging; disease progression and terminal illness underpin high…